Christopher Stone
2017
In 2017, Christopher Stone earned a total compensation of $1.4M as Vice President, General Counsel and Secretary at PDL BioPharma, a 11% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $467,154 |
|---|---|
| Salary | $460,350 |
| Stock Awards | $437,320 |
| Other | $10,000 |
| Total | $1,374,824 |
Stone received $467.2K in non-equity incentive plan, accounting for 34% of the total pay in 2017.
Stone also received $460.4K in salary, $437.3K in stock awards and $10K in other compensation.
Rankings
In 2017, Christopher Stone's compensation ranked 7,421st out of 14,666 executives tracked by ExecPay. In other words, Stone earned more than 49.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,421 out of 14,666 | 49th |
Division Manufacturing | 2,766 out of 5,772 | 52nd |
Major group Chemicals And Allied Products | 897 out of 2,075 | 57th |
Industry group Drugs | 702 out of 1,731 | 59th |
Industry Biological Products, Except Diagnostic Substances | 133 out of 313 | 58th |
Source: SEC filing on April 26, 2018.
Stone's colleagues
We found five more compensation records of executives who worked with Christopher Stone at PDL BioPharma in 2017.